Global Internal Neuromodulation Devices Market poised to reach USD 12.18 billion by 2024

According to Data Bridge Market Research new Market report Global Internal Neuromodulation Devices Market, By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator, Gastric Nerve Stimulator), By Lead Type (Percutaneous, Paddle Lead),By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis), By Battery Type (Primary, Rechargeable), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America, Rest of the World) - Trends and Forecast to 2022, has accounted value of USD 4.12 billion in 2016 and is expected to reach USD 12.18 billion by 2024, growing at a CAGR of 14.5%.Global Internal Neuromodulation Devices Market

Access Full Report: http://databridgemarketresearch.com/reports/global-internal-neuromodulation-devices-market/

The Global Internal Neuromodulation devices market is driven by the rising incidence of failed back surgeries, Parkinson’s disease, urinary incontinence and other related indications. Also the market is experiencing a rising surge of technological advancements such as the new internal Neuromodulation device from Enteromedics for the treatment of obesity related disorders. The market is in its lag phase very soon expected to enter the growth phase, due to major influx of market players in the recent years.

Market Segmentation: Global Internal Neuromodulation Devices Market

The Internal Neuromodulation Devices Market is segmented into 5 product types Spinal Cord Stimulator, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator and Gastric Nerve Stimulator. The Spinal Cord Stimulator segment dominates the internal Neuromodulator devices market globally followed by deep brain Stimulator and vagus nerve stimulator. The market is further segmented based on indications of usage into Failed Back Surgery Syndrome, Conditional Regional pain syndrome, Eschemia, Parkinson’s disease, Alzheimers, Urinary Incontinence, Faecal Incontinenece, Epilepsy, Gastroparesis and others. The product segments are further divided into rechargeable and primary battery types also for spinal cord stimulators the market is divided into 2 lead types percutaneous and paddle lead.

Geographical Segmentation: Global Internal Neuromodulation Devices Market

Based on geography the internal neuromodulation devices market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.  North America is the largest market while Asia-Pacific is the fastest growing market due to the large incidence of Parkinson’s disease in the Asian countries like China. Europe is a developed market with increasing demand for these devices due to good reimbursement scenarios and medical tourisms in countries like Germany, Ireland, Netherlands and others.

Competitive Landscape: Global Internal Neuromodulation Devices Market

The Internal Neuromodulation market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some examples of recent strategies/developments are: August 8, 2016 Medtronic received CE approval for its SureTune2 deep brain stimulator device, St. Jude Medical received FDA approval for Axium its neurostimulation device for dorsal roost ganglion used to treat patients with chronic intractable pain. The report includes market shares of internal Neuromodulation market for global, Europe, North America, Asia Pacific and Rest of the World.

Some of the major players operating in the Global Internal Neuromodulation Market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Inc., Nevro Corporation, Cyberonics, Inc. among other companies. The emerging entrant companies in the U.S. internal neuromodulation market are Neuros Medical, Inc., Inspire Medical Systems Inc., StimGuard LLC, SPR Therapeutics LLC, Neuros Medical Inc.

Browse Related Reports:

Europe Internal Neuromodulation Devices Market, By Product (Spinal Cord Stimulator (By Lead Type (Percutaneous, Paddle Lead)),, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator, Gastric Nerve Stimulator), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis), By Battery Type (Primary, Rechargeable), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) – Trends and Forecast to 2022

http://databridgemarketresearch.com/reports/europe-internal-neuromodulation-devices-market/

 Asia-Pacific Internal Neuromodulation Devices Market, By Product (Spinal Cord Stimulator (By Lead Type (Percutaneous, Paddle Lead)),, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator, Gastric Nerve Stimulator), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis), By Battery Type (Primary, Rechargeable), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare), By Country (China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Taiwan, Indonesia, Australia, Rest of APAC) – Trends and Forecast to 2022 

http://databridgemarketresearch.com/reports/asia-pacific-internal-neuromodulation-devices-market/

Contact:

Data Bridge Market Research

4th Floor, Mega Center,

Magarpatta City, Pune – 411028

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Visit Data Bridge Blog@ http://databridgemarketresearch.com/blog/